Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation.

To investigate a potential role of lipoprotein(a) [Lp(a)] in foam cell formation, we have measured the degradation rates of Lp(a) and LDL in the rabbit aorta in vivo. Lp(a) (or LDL) was labeled with both 113I-TC and 125I and injected into 17 rabbits with extensive aortic atherosclerosis and into 16 rabbits without atherosclerosis. As the protein moiety of the doubly labeled lipoproteins is degraded, 131I-TC is trapped in the cell, whereas 125I diffuses out of the cell. Twenty-four hours after injection, 12 samples of the aorta and biopsies from 9 other tissues were removed. The degradation rate of Lp(a) (percent of plasma pool per gram tissue per day) was less than that of LDL in the adrenals and in the intestine. In contrast, degradation rates of Lp(a) and LDL were similar in liver, spleen, kidney, heart, lung, skeletal muscle, and adipose tissue. In nonlesioned aortic intima-inner media, the degradation rate of Lp(a) was 39% of that of LDL (t test: P <.05 in aortic arch and thoracic aorta), whereas the degradation rates of Lp(a) and LDL were similar in atherosclerotic aortic intima-inner media. Lp(a) degradation rates were markedly increased in atherosclerotic compared with nonlesioned aortic intima-inner media: 28.2+/-9.2 x 10(-7)% and 5.0+/-0.6 x 10(-7)% of the plasma pool per gram tissue per day in the intima-inner media of the proximal segment of atherosclerotic and nonlesioned aorta, respectively (t test: P <.01). These results suggest that the metabolism of Lp(a) is different from that of LDL in nonlesioned arterial intima, possibly reflecting that Lp(a) is degraded by LDL receptors in arterial intima less efficiently than LDL. The results also indicate that the degradation rate of Lp(a) is markedly increased in atherosclerotic lesions of rabbits, supporting the idea that Lp(a) contributes to foam cell formation during the development of atherosclerosis.

[1]  B. Nordestgaard,et al.  In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[2]  B. Nordestgaard,et al.  Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. , 1996, Circulation.

[3]  O. Klezovitch,et al.  Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]. , 1996, Journal of lipid research.

[4]  B. Nordestgaard,et al.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. , 1996, The Journal of clinical investigation.

[5]  B. Nordestgaard,et al.  Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo. , 1996, Circulation research.

[6]  H. Hobbs,et al.  Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). , 1996, The Journal of clinical investigation.

[7]  B. Nordestgaard,et al.  Transfer of lipoprotein(a) and LDL into aortic intima in normal and in cholesterol-fed rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[8]  I. Tabas,et al.  Interferon-gamma down-regulates the lipoprotein(a)/apoprotein(a) receptor activity on macrophage foam cells. Evidence for disruption of ligand-induced receptor recycling by interferon-gamma. , 1994, The Journal of biological chemistry.

[9]  B. Karlberg,et al.  Antiatherosclerotic Effects of the Angiotensin‐Converting Enzyme Inhibitors Captopril and Fosinopril in Hypercholesterolemic Minipigs , 1994, Journal of cardiovascular pharmacology.

[10]  I. Tabas,et al.  Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor. Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  B. Nordestgaard,et al.  Effect of angiotensin II and enalapril on transfer of low-density lipoprotein into aortic intima in rabbits. , 1994, Circulation research.

[12]  D. Rader,et al.  Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease , 1994, Annals of Internal Medicine.

[13]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.

[14]  A. Scanu,et al.  Binding and degradation of lipoprotein(a) and LDL by primary cultures of human hepatocytes. Comparison with cultured human monocyte-macrophages and fibroblasts. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  B. Nordestgaard,et al.  Atherosclerosis in Watanabe heritable hyperlipidaemic rabbits , 1994 .

[16]  B. Nordestgaard,et al.  Atherosclerosis in Watanabe heritable hyperlipidaemic rabbits. Evaluation by macroscopic, microscopic and biochemical methods and comparison of atherosclerosis variables. , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  W. März,et al.  Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor , 1993, FEBS letters.

[18]  P. Weissberg,et al.  Proliferation of human smooth muscle cells promoted by lipoprotein(a). , 1993, Science.

[19]  I. Tabas,et al.  Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. , 1993, The Journal of biological chemistry.

[20]  T. V. van Berkel,et al.  In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats. , 1992, Journal of lipid research.

[21]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[22]  A. Scanu,et al.  Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. , 1992, The Journal of biological chemistry.

[23]  A. Scanu,et al.  Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. , 1992, The Journal of biological chemistry.

[24]  A. Soutar,et al.  Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects. , 1991, Atherosclerosis.

[25]  G. Rice,et al.  Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. , 1991, The Journal of clinical investigation.

[26]  S. Young.  Recent Progress in Understanding Apolipoprotein B , 1990, Circulation.

[27]  J. Loscalzo,et al.  Lipoprotein(a), fibrin binding, and plasminogen activation. , 1990, Arteriosclerosis.

[28]  G. Kostner.  Chapter 13 – The Physiological Role of Lp(a) , 1990 .

[29]  G. Utermann,et al.  The mysteries of lipoprotein(a). , 1989, Science.

[30]  T. Carew,et al.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. , 1989, Arteriosclerosis.

[31]  D. B. Zilversmit,et al.  Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination. , 1989, Journal of lipid research.

[32]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[33]  A. Scanu,et al.  A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.

[34]  R. Zechner,et al.  Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. , 1988, Arteriosclerosis.

[35]  T. Carew,et al.  Quantification In Vivo of Increased LDL Content and Rate of LDL Degradation in Normal Rabbit Aorta Occurring at Sites Susceptible to Early Atherosclerotic Lesions , 1988, Circulation research.

[36]  G. Utermann,et al.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.

[37]  W. Kohr,et al.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. J. Chapman.  [3] Comparative analysis of mammalian plasma lipoproteins , 1986 .

[39]  L. Rudel,et al.  Separation and analysis of lipoproteins by gel filtration. , 1986, Methods in enzymology.

[40]  M. J. Chapman.  Comparative analysis of mammalian plasma lipoproteins. , 1986, Methods in enzymology.

[41]  A. Scanu,et al.  Isolation of apolipoprotein(a) from lipoprotein(a). , 1985, Journal of lipid research.

[42]  T. Carew,et al.  Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta. Predominance of intimal degradation. , 1984, Arteriosclerosis.

[43]  A. Roscher,et al.  The interaction of human apoB-containing lipoproteins with mouse peritoneal macrophages: a comparison of Lp(a) with LDL. , 1984, Journal of lipid research.

[44]  A. Attie,et al.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. , 1983, The Biochemical journal.

[45]  A. Attie,et al.  Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. , 1982, The Journal of biological chemistry.

[46]  M. Brown,et al.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[48]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[49]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[50]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.